HeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High

MT Newswires Live

Sep 22, 2025

HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.

The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.

The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.

The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.

HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2569277498"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569277498\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569277498?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-22 11:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569277498","market":"fut","top_or_hot":-1,"title":"HeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High","media":"MT Newswires Live","content":"<html><body><p> HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.</p><p>The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.</p><p>The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.</p><p>The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.</p><p>HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-22 11:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.</p><p>The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.</p><p>The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.</p><p>The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.</p><p>HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HMD.AU","symbol_name":"HERAMED LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2569277498","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569277498","pubTimestamp":1758511669,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"HeraMED  will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HMD.AU":"HERAMED LTD","BK7007":"医疗保健设备"},"translate_title":"HeraMED计划在12月季度发布人工智能临床医生助理的初始版本；股价接近两年高点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HMD.AU":1},"content_text":"HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}